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Abstract 
 
This study evaluated the potential beneficial effect of Moutan Cortex Radicis (MCR) in a murine model of carbon 
tetrachloride (CCl4)-, D-galactosamine (GalN)- and α-naphthylisothiocyanate (ANIT)-induced liver injury. Acute 
hepatotoxicity was induced by intraperitoneal injection of CCl4 (10 μL/kg), GalN (700 mg/kg), and ANIT (40 mg/kg). 
Animals received MCR (30, 100, and 300 mg/kg ) orally at 48, 24, and 2 h before and 6 h after administration of CCl4, GalN, 
and ANIT. Serum activities of aminotransferase were significantly higher at 24 h after CCl4 or GalN treatment. These changes 
were attenuated by MCR. Histopathological analysis revealed multiple and extensive areas of portal inflammation, 
hepatocellular necrosis, and an increase in inflammatory cell infiltration. These changes were inhibited by MCR. Serum total 
bilirubin concentration increased and bile flow decreased significantly 48 h after ANIT treatment, which was attenuated by 
MCR. Our results suggest that MCR has a protective effect on acute liver injury.  
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Introduction 
 
Liver diseases constitute a major medical problem of worldwide significance and affect high proportions of the 
population (Farghali et al., 2009). Many environmental toxins cause liver injury to humans; despite new advances in 
hepatology, treatment of liver disease does not resolve the problems caused by these toxins. Furthermore, despite 
considerable progress in treatment of liver disease by oral hepatoprotective agents, the search for newer drugs continues due 
to the limitations of existing synthetic drugs (Pushpavalli et al., 2009). Therefore, there has been considerable interest in the 
role of complementary and alternative medicines for treatment of liver diseases. 
Carbon tetrachloride (CCl4)-induced liver injury in a range of laboratory animals is regarded as an analogue of the 
liver damage caused by various hepatotoxins in humans (Muriel, 1998). Involvement of bioactivation by a microsomal 
cytochrome P450-dependent monooxygenase system, resulting in formation of trichloromethyl free radicals, leading to 
hepatocellular damage in hepatic necrosis caused by CCl4 has been suggested (Morio et al., 2001). D-Galactosamine (GalN) 
is a well-established hepatotoxicant that induces a diffuse type of liver injury closely resembling human viral hepatitis 
(Aristatile et al., 2009). GalN-induced liver injury reduces the intracellular pool of uracil nucleotides in hepatocytes, thus 
inhibiting synthesis of RNA and proteins (Siendones et al., 2004). α-Naphthylisothiocyanate (ANIT) is a hepatotoxicant that 
damages biliary cells and hepatocytes; therefore, it is used experimentally in rodents as a model of intrahepatic cholestasis 
(Xu et al., 2004). ANIT is detoxified by glutathione conjugation within hepatocytes and the complex of ANIT-glutathione is 
secreted into bile. However, the ANIT-glutathione conjugate dissociates rapidly in bile, leading to release of the parent 
compound, and exposes biliary epithelial cells to toxic concentrations of ANIT, thus causing hepatobiliary toxicity (Ramaiah 
and Jaeschke, 2007).  
Moutan Cortex Radicis (MCR), the root cortex of Paeonia suffruticosa Andrews (Paeoniaceae), is a well-known 
traditional herbal medicine used in treatment of cardiovascular and female genital diseases (Hirai et al., 1983; Sakamoto et al., 
1992). MCR removes heat from the blood, promotes blood circulation, and removes blood stasis (Chun et al., 2007). MCR 
has potent analgesic, sedative, anti-inflammatory, and anti-microbial properties (Jiang et al., 2007). Furthermore, MCR has a 
protective effect on acetaminophen-induced hepatotoxicity in mice (Shon and Nam, 2004). Paeonol, a major phenolic 
component of MCR, has recently been shown to alleviate alcoholic liver injury via inhibition of hepatic steatosis and 
inflammation (Hu et al., 2010).  
Therefore, this study examined the hepatoprotective effect of MCR against acute hepatotoxicity induced by CCl4, 
GalN, and ANIT. 
 
 
Materials and Methods 
Preparation of an ethanol extract from MCR 
 
MCR (voucher No. 20100107) was purchased from the Kyung-Dong market (Seoul, Korea) and a dried voucher 
specimen was authenticated. 500 g of MCR was extracted in 70% ethanol at room temperature for 24 h, and three times at 55 
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- 60˚C for 4 h in 10 times volume of 70% ethanol. Each extract was filtered through a 150 mesh and concentrated using a 
rotary evaporator (Model: Cosmos 660, KyungSeo Machine Co., Incheon, Korea). The dry powder of extracts was obtained 
by freeze-drying and the yield was 18.0%. MCR was dissolved in 10% Tween 80 (vehicle) for the experiments. 
 
Treatment of animals 
 
Male ICR mice (25-30 g) and Sprague-Dawley rats (190 – 210 g) were obtained from Daehan Biolink Co., Ltd., 
(Eumseong, Korea) and acclimatized to the laboratory conditions at Sungkyunkwan University for at least one week. Animals 
were maintained in a room with controlled temperature and humidity (25 ± 1˚C and 55 ± 5%, respectively) with a 12 h 
alternating light–dark cycle. Prior to experimentation, the animals were fasted for 18 h, but given tap water ad libitum. All 
animals were treated humanely under the Sungkyunkwan University Animal Care Committee Guidelines.  
 
CCl4–induced hepatotoxicity in mice 
 
CCl4 was dissolved in olive oil and administered intraperitoneally (10 μL/kg). Mice were randomly assigned to 
five groups: i) vehicle-treated control; ii) vehicle-treated CCl4; iii) MCR 30 (30 mg/kg)-treated CCl4; iv) MCR 100 (100 
mg/kg)-treated CCl4; v) MCR 300 (300 mg/kg)-treated CCl4. MCR was administered orally at 48 h, 24 h, and 2 h before and 
6 h after CCl4 injection. Dose and timing of MCR were selected based on our preliminary studies. Blood samples were taken 
from the abdominal aorta and the liver was removed 24 h after CCl4 treatment. 
 
GalN–induced hepatotoxicity in rats 
 
GalN was dissolved in phosphate buffered saline (PBS) and administered intraperitoneally (700 mg/kg). Rats were 
randomly assigned to five groups: i) vehicle-treated control; ii) vehicle-treated GalN; iii) MCR 30 (30 mg/kg)-treated GalN; 
iv) MCR 100 (100 mg/kg)-treated GalN; v) MCR 300 (300 mg/kg)-treated GalN. MCR was administered orally at 48 h, 24 h, 
and 2 h before and 6 h after GalN injection. Blood samples were taken from the abdominal aorta and the liver was removed 
24 h after GalN treatment.  
 
ANIT–induced hepatotoxicity in rats 
 
ANIT was dissolved in olive oil and injected intraperitoneally (40 mg/kg). Rats were randomly assigned to five 
groups: i) vehicle-treated control; ii) vehicle-treated ANIT; iii) MCR 30 (30 mg/kg)-treated ANIT; iv) MCR 100 (100 
mg/kg)-treated ANIT; v) MCR 300 (300 mg/kg)-treated ANIT. MCR was administered orally 48 h, 24 h, and 2 h before and 6 
h after ANIT injection. Blood samples were taken from the abdominal aorta and the liver was removed 48 h after ANIT 
treatment. 
 
Serum aminotransferase activities and total bilirubin concentration 
 
Levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity and total bilirubin 
(TBIL) concentration were determined by standard spectrophotometric procedures using the ChemiLab ALT, AST, and TBIL 
assay kits (IVDLab Co., Ltd., Uiwang, Korea), respectively. 
 
Histological analysis 
 
The anterior portion of the left lateral lobe of the liver was sectioned and used for histological analysis. Tissues 
were fixed by immersion in 10% neutral-buffered formalin. Samples were then embedded in paraffin, sliced into 5 μm 
sections, stained with hematoxylin-eosin, followed by blinded histological assessment. The degree of portal inflammation, 
hepatocellular necrosis, and inflammatory cell infiltration was evaluated (Frei et al., 1984). Histological changes were 
evaluated in non-consecutive, randomly chosen x 400 histological fields. 
 
Bile flow 
 
At 48 h after ANIT treatment, rats were anesthetized intraperitoneally with ketamine (60 mg/kg body weight) and 
xylazine (10 mg/kg body weight) and placed on a heating pad in order to maintain body temperature. A midline incision was 
made in the rat, and the common bile duct was isolated and cannulated with PE 10 tubing. Bile was collected for a 60 min 
period. Bile and liver samples were weighed, and bile flow was calculated, assuming a density of 1 g/mL. 
 
Statistical analysis 
 
The overall significance of the results was examined using one-way analysis of variance (ANOVA). Differences 
between the groups were considered statistically significant at P < 0.05 with the appropriate Bonferroni correction made for 
multiple comparisons. Results are presented as mean ± S.E.M.  
 
 
Results and Discussion  
 
In this study, the protective effect of MCR was examined using a model of CCl4-, GalN, and ANIT-induced 
doi: 10.4314/ajtcam.v8i5S.2
Park et al., Afr J Tradit Complement Altern Med. (2011) 8(S):220-225 
222 
 
222
hepatotoxicity. CCl4, a classic hepatotoxin, caused acute, reversible liver injury characterized by centrilobular necrosis (Son 
et al., 2007). Hepatotoxicity of CCl4 is thought to involve two phases. The first phase consists of activation by cytochrome 
P450 2E1, 2B1, or 2B2 in the liver to form a highly reactive trichloromethyl radical and then a trichloromethyl peroxy radical 
(Yamaji et al., 2008). These radicals can attack membrane phospholipid stimulating lipid peroxidation and cell lysis. This 
damage to the structural integrity of the liver was observed from elevated serum levels of hepatospecific enzymes, i.e. AST 
and ALT (Aktay et al., 2000). The second phase is caused by the inflammatory response, which involves activation of 
Kupffer cells, probably by free radicals. Activation of Kupffer cells is accompanied by production of proinflammatory 
mediators (Chen et al., 2004).  
As shown in Table 1, serum ALT activity in the control group averaged 25.5 ± 1.2 U/L. However, the value in the 
vehicle-treated CCl4 group showed a dramatic increase (1983.0 ± 28.6 U/L, P < 0.01), indicating severe hepatocellular 
damage. Treatment with MCR, at doses of 30, 100, and 300 mg/kg resulted in a markedly attenuated increase in ALT activity 
to approximately 66.3%, 54.3%, and 37.3% of that in the vehicle-treated CCl4 group, respectively. Consistent with the ALT 
data, the serum level of AST increased significantly from 46.4 ± 6.7 U/L to 1764.0 ± 158.1 U/L, and this increase was 
reduced by 30, 100, and 300 mg/kg of MCR. Histological observation of liver samples strongly supported the release of 
aminotransferases by damaged hepatocytes, as well as the protective effect of MCR. The histological features shown in 
Figure 1A demonstrated normal liver lobular architecture and cell structure in the control group. In contrast, the vehicle-
treated CCl4 group exhibited various histological changes to the liver, including cell necrosis, fatty metamorphosis in 
adjacent hepatocytes, ballooning degeneration, cell inflammation, and infiltration of lymphocytes and Kupffer cells (Figure 
1B). These alterations were significantly attenuated by 300 mg/kg of MCR, showing mild hepatocellular necrosis and 
inflammation (Figure 1C). These results suggest that MCR may have potential clinical applications for treatment of liver 
disorders. 
In terms of both morphological and functional aspects, GalN-induced acute injury in rat livers is well-established 
and recognized as resembling viral hepatitis in humans (Decker and Keppler, 1972). The toxic effect of GalN is connected 
with an insufficiency of UDP-glucose and UDP-galactose, as well as loss of intracellular calcium homeostasis. These 
changes affect cell membranes and organelles, as well as synthesis of proteins and nucleic acids (Devaki et al., 2009). Recent 
studies have demonstrated that GalN can induce hepatic hypoxia/hypoperfusion and trigger production of reactive oxygen 
species from affected hepatocytes, infiltrated leukocytes, and activated Kupffer cells and enhance mitochondrial apoptosis- 
and the proinflammatory cytokine-signaling pathway, contributing to oxidative stress and inflammation in the liver (Lin et al., 
2009).  
 
Table 1: Effect of MCR on serum aminotransferase activities in mice after CCl4 administration 
 
The results are presented as mean ± S.E.M. of 8-10 mice per group. ** Denotes significant differences (P < 0.01) compared 
with the control group; #, ## denote significant differences (P < 0.05, P < 0.01) compared with the vehicle-treated CCl4 group. 
ALT: alanine aminotransferase; AST: aspartate aminotransferase; MCR: Moutan Cortex Radicis.  
 
 
Table 2: Effect of MCR on serum aminotransferase activities in rats after GalN administration 
 
The results are presented as mean ± S.E.M. of 8-10 rats per group. ** Denotes significant differences (P < 0.01) compared 
with the control group; #, ## denote significant differences (P < 0.05, P < 0.01) compared with the vehicle-treated GalN group. 
ALT: alanine aminotransferase; AST: aspartate aminotransferase; MCR: Moutan Cortex Radicis. 
 
 
 
 
 
Group Dose (mg/kg) ALT (U/L) AST (U/L) 
Control   25.5 ± 1.2 46.4 ± 6.7 
CCl4     
 Vehicle   1983.0 ± 28.6**   1764.0 ± 158.1** 
 MCR 30     1316.0 ± 196.2**, ##     1181.0 ± 128.0**, ## 
  100     1076.0 ± 120.1**, ##    1239.0 ± 94.5**, # 
  300      739.4 ± 174.2**, ##      960.3 ± 86.7**, ## 
Group Dose (mg/kg) ALT (U/L) AST (U/L) 
Control   44.4 ± 1.0 81.5 ± 0.8 
GalN     
 Vehicle   235.7 ± 28.6**  664.6 ± 41.7** 
 MCR 30   168.8 ± 9.2**, #    539.4 ± 27.5**, # 
  100    155.9 ± 13.3**, #     468.8 ± 18.8**, ## 
  300    148.3 ± 19.2**, #    530.1 ± 28.3**, # 
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Figure 1: Histological features of liver sections stained with hematoxylin and eosin at 24 h after CCl4 (A-C) or GalN (D-F) 
exposure. Typical images were chosen from each experimental group (original magnification ×400). (A): The control group, 
showing normal lobular architecture and cell structure; (B): The vehicle-treated CCl4 group, showing multiple and extensive 
areas of portal inflammation and hepatocellular necrosis, and a moderate increase in inflammatory cell infiltration; (C): CCl4 
+ MCR (300 mg/kg) group, showing minimal hepatocellular necrosis and inflammatory cell infiltration, and mild portal 
inflammation; (D): The control group, showing normal hepatic architecture; (E): The vehicle-treated GalN group, showing 
hepatocellular necrosis with extensive inflammation and inflammatory cell infiltration; (F): GalN + MCR (300 mg/kg) group, 
showing mild hepatocellular necrosis and inflammatory infiltration.     
 
 
In the present study, serum ALT activity in the control group was 44.4 ± 1.0 U/L. The vehicle-treated GalN group 
showed a significant increase in serum ALT activity at 24 h after GalN injection (235.7 ± 28.6 U/L, P < 0.01). In contrast, 
treatment with MCR at doses of 30, 100, and 300 mg/kg attenuated the increase in ALT activity to approximately 71.6%, 
66.1%, and 62.9% of that in the vehicle-treated GalN group, respectively. The serum level of AST also showed a significant 
increase from 81.5 ± 0.8 U/L to 664.6 ± 41.7 U/L, and this increase was reduced by 30, 100, and 300 mg/kg of MCR (Table 
2). The histological features shown in Figure 1D demonstrate normal liver lobular architecture and cell structure in the 
control group. However, livers exposed to GalN showed multiple and extensive areas of portal inflammation and 
hepatocellular necrosis, randomly distributed throughout the parenchyma, as well as a moderate increase in inflammatory cell 
infiltration (Figure 1E). These pathological changes were attenuated by 300 mg/kg of MCR (Figure 1F). Taken together, our 
results suggest that MCR has a potential for use as a therapeutic agent for treatment of acute hepatitis. 
The key function of the liver is to synthesize, concentrate, and secrete bile acids and to excrete other toxicants, 
such as bilirubin. ANIT induces bile duct epithelial cell necrosis, followed by cessation of bile flow, and consequent 
hyperbilirubinemia (Hasegawa et al., 2008). Due to its dose-dependent effects and high reproducibility between studies, 
ANIT is a typical hepatotoxin used in the study of intrahepatic cholestasis (Hasegawa et al., 2008). This drug provokes an 
acute cholestatic hepatitis, due in part to its recycling through repeated rounds of glutathione conjugation and biliary 
excretion (Kodali et al., 2006). The drug is initially detoxified in hepatocytes by conjugation with glutathione (Xu et al., 
2004). Instability of the ANIT-glutathione conjugate and recycling rounds of ANIT metabolism result in high ANIT 
concentration in bile (Luyendyk et al., 2009). This causes bile duct epithelial cell damage and formation of foci of hepatic 
necrosis characterized by dead hepatocytes (Luyendyk et al., 2009).  
According to our results, serum TBIL concentration was 0.077 ± 0.027 mg/dL in the control group. However, the 
vehicle-treated ANIT group showed significantly increased serum TBIL concentration by approximately 8.6 times that of the 
control group. Treatment with MCR at doses of 100 and 300 mg/kg attenuated an increase in TBIL concentration to 
approximately 62.5% and 36.1% of that in the vehicle-treated ANIT group, respectively (Figure 2A). Bile flow in the control 
group was 2.249 ± 0.252 mL/min/g liver. In the vehicle-treated ANIT group, bile flow showed a significant decrease (0.379 ± 
0.023 mL/min/g liver, P < 0.01); however, treatment with MCR, at doses of 30, 100 and 300 mg/kg attenuated this decrease 
in bile flow (Figure 2B). These results indicate that MCR may offer protection to hepatocytes and bile duct epithelial cells 
against acute liver cholestasis.  
 
Conclusion  
 
MCR may prevent CCl4-, GalN-, and ANIT-induced acute hepatic injury. This study provides evidence of the 
potential of MCR as an alternative treatment for liver diseases. Further studies will be needed in order to achieve a full 
understanding of the underlying mechanism in the hepatoprotective effect of MCR against acute hepatotoxicity. 
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Figure 2: Effect of MCR on serum total bilirubin (A) and bile flow (B) in ANIT-induced acute hepatotoxicity. The values are 
represented as mean ± S.E.M. for 8-10 rats per group. ** Denotes significant differences (P < 0.01) compared with the control 
group; +, ++ denote significant differences (P < 0.05, P < 0.01) compared with the vehicle-treated ANIT group. ANIT: α-
naphthylisothiocyanate; TBIL: total bilirubin; MCR: Moutan Cortex Radicis. 
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